August 2023. ETHRA wrote to members of SANT in anticipation of the presentation of the Rapporture's Draft Report on non-communicable diseases. We highlighted that 'tobacco use' was erroneously identified as a risk fact, when it should be smoking. We also outlined the import role safer nicotine products can have in reducing smoking and NCD prevalence.
Read more: ETHRA letter to the SANT Committee on non-communicable diseases
July 2023. ETHRA participated in a targeted stakeholder interview which was the final part of the European Commission's consultation on the evaluation of the legislative framework for tobacco control. ETHRA partner Damian Sweeney and public health partner Clive Bates represented ETHRA in the interview. A summary of the questions and answers is below.
Download our summary here.
Read more: Study supporting the evaluation of the Tobacco control Acquis - Stakeholder Interview
May 2023. ETHRA submitted to the European Commission's public consultation on the evaluation of the legislative framework for tobacco control. The consultation was in the form of a questionnaire with the option to attach a supporting document. Due to the inherent bias against tobacco harm reduction in the questionnaire, our supporting document was our main contribution to the consultation.
Download our submission here
See the questionnaire here
Read more: Evaluation of the legislative framework for tobacco control – Open Public Consultation
April 2023. ETHRA submitted to Norway's TRIS consultation on amendments to the Tobacco Control Act which would introduce plain packaging and a flavour ban for all e-liquids.
Download our submission here
March 2023. ETHRA participated in a targeted stakeholder consultation on extending smoke free environment recommendations to included vaping and heated tobacco products.
Read more: ETHRA submission to targeted consultation - Survey for Smoke-Free Environments